Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation affects a meaningful number of people who start Wegovy, and the good news is that several practical steps can significantly reduce the risk. Semaglutide slows the movement of food through the digestive tract — that same mechanism is part of why it reduces appetite, but it also means your bowel has more time to absorb water from stool. Understanding this ahead of your first dose puts you in a much stronger position than waiting for a problem to appear. These are prescription-only medicines requiring clinical assessment before you begin, and your prescriber will talk you through what to expect before treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
In the STEP 1 trial (68 weeks, nearly 2,000 adults with obesity, semaglutide 2.4mg versus placebo) gastrointestinal side effects as a group were the most common reason for stopping treatment, and constipation featured consistently throughout the titration phase. The NHS medicines page for semaglutide lists constipation among the common side effects, alongside nausea, diarrhoea and stomach discomfort. It does not tend to strike everyone, but it is common enough that planning for it is worth your time, and our dedicated page on Wegovy constipation explains exactly what to expect and why it happens. The mechanism is straightforward: semaglutide activates GLP-1 receptors in the gut wall, which slows transit time. Slower transit means the colon extracts more water from stool, producing the firm, infrequent movements most people describe. Dose increases are often the trigger point, so the weeks after moving from 0.25mg to 0.5mg, or from 1.0mg to 1.7mg, are the periods to be most attentive. Our full overview of Wegovy's side effect profile sets this in context alongside nausea and other GI changes you might notice.
Hydration comes first. When gastric emptying slows, the colon compensates by pulling more fluid from whatever passes through it, if your overall fluid intake is low, stool becomes noticeably harder. Aim to drink consistently through the day rather than in one large volume at once; many people find the simplest habit is a glass of water with each of their (now smaller) meals. A quick check: your urine should be pale yellow; dark yellow is a reliable sign you need more fluid. Fibre is the second lever. Soluble fibre (from oats, lentils, apples, and similar foods) absorbs water and keeps stool softer. Insoluble fibre, from wholegrains and vegetables, adds bulk and encourages movement. Both matter, but if you are only going to make one food change, adding a portion of vegetables to each meal and swapping refined carbohydrates for wholegrains covers both categories at once. Movement is the third. Regular physical activity stimulates the muscles of the gut wall through a mechanism that has nothing to do with calorie burn. Even a 20-minute walk after meals has good evidence behind it for bowel regularity. Our guide on treating constipation once it appears covers what to do if prevention is not enough, and the full side effects list for Wegovy adds further context.
Constipation that is uncomfortable but manageable is common early in treatment and usually settles as your body adjusts to semaglutide. Not passing stool for three or more days, experiencing significant bloating, or finding that over-the-counter remedies are not helping after a few days, all of these are worth mentioning to your prescriber or aftercare team. Do not simply push through, because bowel discomfort that worsens can occasionally signal something unrelated to Wegovy. Urgent medical help is needed if you develop severe stomach pain, particularly pain that radiates to your back, with or without vomiting. This pattern is not typical of constipation; it may indicate acute pancreatitis, which the MHRA Drug Safety Update of January 2026 identified as a known, though infrequent, serious risk with GLP-1 medicines. Go to A&E or call 999 if this happens. For anything less acute, you can report a suspected side effect through the MHRA Yellow Card scheme, patient reports genuinely contribute to ongoing safety monitoring of newer medicines. At nume, our prescribers discuss the full side effect picture, including constipation and how to manage it, as part of the consultation before treatment is approved. You can also read how people typically manage nausea on Wegovy alongside constipation, since both often appear during the same titration windows.
Wegovy is a prescription-only medicine. The only legal route to it in the UK is a prescription following clinical assessment by a registered prescriber, and the quality of that assessment matters. Unregulated sellers, particularly those promoting these medicines online without any clinical process, have been linked to counterfeit products that have caused real harm. Before using any online pharmacy, check it holds a valid GPhC registration using the GPhC pharmacy register. You can verify our own registration there. If you are ready to discuss whether Wegovy is suitable for you, our free consultation page explains exactly how the process works, and our Wegovy overview covers the treatment in full detail. For general questions about your options, the treatment overview is a useful starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.